PA
PARN

Perceptive Advisors’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Perceptive Advisors’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-68,800
Closed -$341K – 210
2015
Q2 		$341K Sell
68,800
-127,700
-65% -$563K 0.02% 138
2015
Q1 		$964K Sell
196,500
-17,600
-8% -$81.4K 0.07% 103
2014
Q4 		$888K Buy
214,100
+4,100
+2% +$18.6K 0.07% 104
2014
Q3 		$1.21M Buy
+210,000
New +$1.26M 0.12% 82

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors's PARN Position: Q3 2015 in Review

Perceptive Advisors sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q3 2015, closing a stake of 68,800 shares — an estimated $341K sold.

Perceptive Advisors first reported a position in PARN in Q3 2014 and held it in 4 quarters. The position peaked at $1.21M in Q3 2014. 10 funds tracked by Wall St. Rank hold PARN as of Q3 2015.

  • Perceptive Advisors reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q3 2015 after selling out during the quarter.
  • Perceptive Advisors sold 68,800 Parnell Pharmaceuticals Holdings Ltd shares in Q3 2015, an estimated $341K.
  • Perceptive Advisors first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and held it in 4 quarters.
  • Perceptive Advisors's Parnell Pharmaceuticals Holdings Ltd position peaked at $1.21M in Q3 2014.
  • 10 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q3 2015.

Based on Perceptive Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.